Literature DB >> 21914008

Inhibition of 5α-reductase activity in late pregnancy decreases gestational length and fecundity and impairs object memory and central progestogen milieu of juvenile rat offspring.

J J Paris1, P J Brunton, J A Russell, A A Walf, C A Frye.   

Abstract

Psychological, physical and/or immune stressors during pregnancy are associated with negative birth outcomes, such as preterm birth and developmental abnormalities. In rodents, prenatal stressors can alter the expression of 5α-reductase enzymes in the brain and may influence cognitive function and anxiety-type behaviour in the offspring. Progesterone plays a critical role in maintaining gestation. In the present study, it was hypothesised that 5α-reduced progesterone metabolites influence birth outcomes and/or the cognitive and neuroendocrine function of the offspring. 5α-Reduced steroids were manipulated in pregnant Long-Evans rats via the administration of vehicle, the 5α-reduced, neuroactive metabolite of progesterone, 5α-pregnan-3α-ol-20-one (3α,5α-THP, allopregnanolone; 10 mg/kg/ml, s.c.), or the 5α-reductase inhibitor, finasteride (50 mg/kg/ml, s.c.), daily from gestational days 17-21. Compared to vehicle or 3α,5α-THP treatment, finasteride, significantly reduced the length of gestation and the number of pups per litter found in the dams' nests after parturition. The behaviour of the offspring in hippocampus-dependent tasks (i.e. object recognition, open field) was examined on post-natal days 28-30. Compared to vehicle-exposed controls, prenatal 3α,5α-THP treatment significantly increased motor behaviour in females compared to males, decreased progesterone content in the medial prefrontal cortex (mPFC) and diencephalon, increased 3α,5α-THP and 17β-oestradiol content in the hippocampus, mPFC and diencephalon, and significantly increased serum corticosterone concentrations in males and females. Prenatal finasteride treatment significantly reduced object recognition, decreased hippocampal 3α,5α-THP content, increased progesterone concentration in the mPFC and diencephalon, and increased serum corticosterone concentration in female (but not male) juvenile offspring, compared to vehicle-exposed controls. Thus, inhibiting the formation of 5α-reduced steroids during late gestation in rats reduces gestational length, the number of viable pups per litter, and impairs cognitive and neuroendocrine function in the juvenile offspring.
© 2011 The Authors. Journal of Neuroendocrinology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914008      PMCID: PMC3196810          DOI: 10.1111/j.1365-2826.2011.02219.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  72 in total

Review 1.  Long-term plasticity of postsynaptic GABAA-receptor function in the adult brain: insights from the oxytocin neurone.

Authors:  A B Brussaard; A E Herbison
Journal:  Trends Neurosci       Date:  2000-05       Impact factor: 13.837

2.  Late-preterm birth and its association with cognitive and socioemotional outcomes at 6 years of age.

Authors:  Nicole M Talge; Claudia Holzman; Jianling Wang; Victoria Lucia; Joseph Gardiner; Naomi Breslau
Journal:  Pediatrics       Date:  2010-11-22       Impact factor: 7.124

3.  Juvenile offspring of rats exposed to restraint stress in late gestation have impaired cognitive performance and dysregulated progestogen formation.

Authors:  Jason J Paris; Cheryl A Frye
Journal:  Stress       Date:  2010-10-31       Impact factor: 3.493

4.  The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development.

Authors:  Elysia P Davis; Curt A Sandman
Journal:  Child Dev       Date:  2010 Jan-Feb

5.  Prenatal treatment with glucocorticoids sensitizes the hpa axis response to stress among full-term infants.

Authors:  Elysia Poggi Davis; Feizal Waffarn; Curt A Sandman
Journal:  Dev Psychobiol       Date:  2010-11-23       Impact factor: 3.038

Review 6.  Novel pathways for implantation and establishment and maintenance of pregnancy in mammals.

Authors:  Fuller W Bazer; Guoyao Wu; Thomas E Spencer; Greg A Johnson; Robert C Burghardt; Kayla Bayless
Journal:  Mol Hum Reprod       Date:  2009-10-30       Impact factor: 4.025

Review 7.  Finasteride treatment of hair loss in women.

Authors:  Stephen M Stout; Janice L Stumpf
Journal:  Ann Pharmacother       Date:  2010-05-04       Impact factor: 3.154

8.  Locomotor and stress responses to nicotine differ in adolescent and adult rats.

Authors:  Junran Cao; James D Belluzzi; Sandra E Loughlin; Jasmin M Dao; Yiling Chen; Frances M Leslie
Journal:  Pharmacol Biochem Behav       Date:  2010-04-25       Impact factor: 3.533

9.  The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.

Authors:  Timothy J Rafael; A Dhanya Mackeen; Vincenzo Berghella
Journal:  Am J Perinatol       Date:  2011-03-04       Impact factor: 1.862

10.  Prenatal social stress in the rat programmes neuroendocrine and behavioural responses to stress in the adult offspring: sex-specific effects.

Authors:  P J Brunton; J A Russell
Journal:  J Neuroendocrinol       Date:  2010-01-27       Impact factor: 3.627

View more
  12 in total

Review 1.  Pregnane xenobiotic receptors and membrane progestin receptors: role in neurosteroid-mediated motivated behaviours.

Authors:  C A Frye; C J Koonce; A A Walf
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

2.  Development and validation of an LC-MS/MS assay for the quantification of allopregnanolone and its progesterone-derived isomers, precursors, and cortisol/cortisone in pregnancy.

Authors:  G Mayne; E De Bloois; D Dabelea; U Christians
Journal:  Anal Bioanal Chem       Date:  2021-07-19       Impact factor: 4.142

Review 3.  Neuroimmunology of the female brain across the lifespan: Plasticity to psychopathology.

Authors:  R M Barrientos; P J Brunton; K M Lenz; L Pyter; S J Spencer
Journal:  Brain Behav Immun       Date:  2019-03-11       Impact factor: 7.217

4.  Immune stress in late pregnant rats decreases length of gestation and fecundity, and alters later cognitive and affective behaviour of surviving pre-adolescent offspring.

Authors:  Jason J Paris; Paula J Brunton; John A Russell; Cheryl A Frye
Journal:  Stress       Date:  2011-11       Impact factor: 3.493

5.  5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat.

Authors:  Jason J Paris; ShiPing Zou; Yun K Hahn; Pamela E Knapp; Kurt F Hauser
Journal:  Brain Behav Immun       Date:  2016-01-13       Impact factor: 7.217

Review 6.  Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autism.

Authors:  Andrea C Gore; Katherine M Martien; Khatuna Gagnidze; Donald Pfaff
Journal:  Endocr Rev       Date:  2014-09-11       Impact factor: 19.871

Review 7.  Progestogens' effects and mechanisms for object recognition memory across the lifespan.

Authors:  Alicia A Walf; Carolyn J Koonce; Cheryl A Frye
Journal:  Behav Brain Res       Date:  2015-07-30       Impact factor: 3.332

8.  Prenatal Stress Alters Progestogens to Mediate Susceptibility to Sex-Typical, Stress-Sensitive Disorders, such as Drug Abuse: A Review.

Authors:  Cheryl A Frye; Jason J Paris; Danielle M Osborne; Joannalee C Campbell; Tod E Kippin
Journal:  Front Psychiatry       Date:  2011-10-17       Impact factor: 4.157

Review 9.  Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor.

Authors:  Cheryl A Frye; Carolyn J Koonce; Alicia A Walf
Journal:  Front Cell Neurosci       Date:  2014-04-09       Impact factor: 5.505

10.  Gestational or acute restraint in adulthood reduces levels of 5α-reduced testosterone metabolites in the hippocampus and produces behavioral inhibition of adult male rats.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Front Cell Neurosci       Date:  2012-12-18       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.